Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OX40L–OX40 Signaling in Atopic Dermatitis
Masutaka Furue, Mihoko Furue
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2578-2578
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial
Stephan Weidinger, Thomas Bieber, Michael J. Cork, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 531-539
Open Access | Times Cited: 43
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 24
From Emollients to Biologicals: Targeting Atopic Dermatitis
Lorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10381-10381
Open Access | Times Cited: 56
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
Ana Maria Lé, Tiago Torres
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2753-2753
Open Access | Times Cited: 46
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
El‐Bdaoui Haddad, Sonya Cyr, Kazuhiko Arima, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 7, pp. 1501-1533
Open Access | Times Cited: 44
Hyaluronic Acid Hydrogel Containing Resveratrol-Loaded Chitosan Nanoparticles as an Adjuvant in Atopic Dermatitis Treatment
Raffaele Conte, Ilenia De Luca, Anna Valentino, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 2, pp. 82-82
Open Access | Times Cited: 29
Therapeutic potential of microneedles based delivery systems for the management of atopic dermatitis
Shalini Shukla, Kalpana Mamale, Rajeshwar Kamal Kant Arya, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104493-104493
Closed Access | Times Cited: 23
Enhanced detection of antigen-specific T cells by a multiplexed AIM assay
Audrée Lemieux, Gérémy Sannier, Alexandre Nicolas, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 1, pp. 100690-100690
Open Access | Times Cited: 7
Atopic Dermatitis Itch: Scratching for an Explanation
Georgia Biazus Soares, Takashi Hashimoto, Gil Yosipovitch
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 5, pp. 978-988
Closed Access | Times Cited: 7
An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 7
Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
Yiqiao Chen, C.E.M. Griffiths, Silvia Bulfone‐Paus
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1564-1564
Open Access | Times Cited: 18
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis
Barbara Rewerska, Lawrence Sher, Sady Alpizar, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100195-100195
Open Access | Times Cited: 18
Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
Hisato Iriki, Hayato Takahashi, Masayuki Amagai
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 4, pp. 545-553
Open Access | Times Cited: 17
The Role of OX40–OX40L Axis in the Pathogenesis of Atopic Dermatitis
Natale Schettini, Lucrezia Pacetti, Monica Corazza, et al.
Dermatitis (2024)
Closed Access | Times Cited: 5
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Ayaka Sato, Hodaka Nagai, Ayano Suzuki, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Role of Siglec‐E in MC903‐Induced Atopic Dermatitis
Mari Nakanishi, Risa Tamagawa‐Mineoka, Hiromi Nishigaki, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 2
Closed Access
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Emma Guttman‐Yassky, Eric L. Simpson, Robert Bissonnette, et al.
Immunotherapy (2025), pp. 1-12
Open Access
OX40 ligand promotes follicular helper T cell differentiation and development in mice with immune thrombocytopenia
Ziyin Yang, Lei Hai, Xiaoyu Chen, et al.
Journal of Zhejiang University SCIENCE B (2025)
Closed Access
Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets
Junhu Tai, Mun Soo Han, Tae Hoon Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5523-5523
Open Access | Times Cited: 23
Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation
Eri Sakamoto, Yasuhiro Katahira, Izuru Mizoguchi, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 123-123
Open Access | Times Cited: 13
The role of OX40 ligand/OX40 axis signalling in atopic dermatitis
Emma Guttman‐Yassky, Michael Croft, Bob Geng, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 488-496
Open Access | Times Cited: 4
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
José Miguel Alvarenga, Thomas Bieber, Tiago Torres
Drugs (2024)
Open Access | Times Cited: 4
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside
Giulia Radi, Anna Campanti, Federico Diotallevi, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2700-2700
Open Access | Times Cited: 18
T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
Chunjiao Zheng, Yuling Shi, Ying Zou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Emerging Systemic Treatment Options in Atopic Dermatitis
Andaç Salman, Ana M. Giménez‐Arnau
Balkan Medical Journal (2024), pp. 239-247
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top